sle, I believe NOX will hold about 40% of NYR if performance...

First 6 Last

Share
Profile

Follow
RBx

643 Posts.

1002

12/01/20

14:29

Post #: 42340021
Share

Originally posted by sle ↑

It's about 30 ish per cent with the dilution. I'm wondering whether news of these events will occur this month?

(1) To help elevate the Company’s profile in the PCSK9
drug development field, Nyrada has put together a
scientific paper of its successful research and
development results and is in the process of
submitting the paper to a well-respected, peer reviewed journal. The paper is anticipated to be
published towards the end of 2019.

(2) Recently, the Company has identified another
compound that it believes also could be efficacious
in the treatment of neuropathic pain. Both this
newly identified compound and NYX-205 are now set
to go head-to-head in an animal model of sciatica.
Nyrada has engaged with the global research
organisation Shanghai ChemPartners to conduct a
pre-clinical study on the efficacy of both compounds
in the treatment of sciatic nerve-associated pain.
One well-established animal model of sciatica is
called the Chronic Constriction Injury (CCI) model.
Shanghai ChemPartner will test both compounds in
the CCI model to determine what the likely success
of either compound in the treatment of neuropathic
pain would be. The readout from this study is
anticipated in the second half of 2019 and will
determine which compound is taken further into
pre-clinical testing.

Expand

sle,

I believe NOX will hold about 40% of NYR if performance milestones are achieved. These milestones are an SP of 40 cents AND neuroprotectant/neuropathic drug candidates judged ready to proceed to pre-clinical safety and toxicity studies.

NYR Price at posting: 0.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

PAM

PAM secures high-grade Chilean copper play in strong territory

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

IVZ

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

AZL

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

There are more pages in this discussion • 5 more messages in this thread...

First 6 Last

Add NYR (ASX) to my watchlist

(20min delay)
Last 5.4¢		Change 0.001(1.89%)		Mkt cap ! $10.20M

Open	High	Low	Value	Volume
5.3¢	5.6¢	5.3¢	$5.863K	105.2K

Buyers (Bids)

No.	Vol.	Price($)
2	97297	5.3¢

Sellers (Offers)

Price($)	Vol.	No.
5.6¢	3467	1

View Market Depth

No.	Vol.	Price($)
2	97297	0.053
1	200000	0.050
3	140989	0.049
2	220812	0.048
2	33739	0.046

Price($)	Vol.	No.
0.056	3467	1
0.057	177449	3
0.058	172400	1
0.060	10000	1
0.062	9000	1

Last trade - 12.33pm 29/07/2024 (20 minute delay)

NYR (ASX) Chart

sle, I believe NOX will hold about 40% of NYR if performance...

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

PAM secures high-grade Chilean copper play in strong territory

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

sle, I believe NOX will hold about 40% of NYR if performance...

Top Stories

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

PAM secures high-grade Chilean copper play in strong territory

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News